Natacha Le Moan

Dr. Le Moan brings more than 10 years of industry experience in translational research and platform technologies across multiple therapeutic areas including neurological, ophthalmology, and inflammatory disorders. Prior to joining Ashvattha, Dr. Le Moan served as Executive Director of Translational Research at Catalyst Biosciences, where she led discovery and IND-stage programs, expanded the company’s preclinical portfolio, and was responsible for generating the disease area strategy for discovery programs. Prior to Catalyst, Dr. Le Moan was Director of Translational Research at Omniox, leading the company’s research team on early-stage and development activities and building productive academic collaborations and pharma partnerships. Dr. Le Moan holds a Ph.D. in Molecular Biology from Paris-Sud University and was a postdoctoral fellow at the Gladstone Institute of Neurological Disease, University of California San Fransisco. In addition to authoring numerous research papers and abstracts, Dr. Le Moan was a PI on NIH research grants and is an inventor on multiple patents.